CY2013003I2 - Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων - Google Patents

Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων

Info

Publication number
CY2013003I2
CY2013003I2 CY2013003C CY2013003C CY2013003I2 CY 2013003 I2 CY2013003 I2 CY 2013003I2 CY 2013003 C CY2013003 C CY 2013003C CY 2013003 C CY2013003 C CY 2013003C CY 2013003 I2 CY2013003 I2 CY 2013003I2
Authority
CY
Cyprus
Prior art keywords
phosphonochemical
derivatives
preparation
phosphonochemical derivatives
Prior art date
Application number
CY2013003C
Other languages
English (en)
Other versions
CY2013003I1 (el
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18417716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2013003(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of CY2013003I1 publication Critical patent/CY2013003I1/el
Publication of CY2013003I2 publication Critical patent/CY2013003I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
CY2013003C 1997-12-19 2013-01-07 Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων CY2013003I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35149997 1997-12-19
PCT/JP1998/005709 WO1999032497A1 (en) 1997-12-19 1998-12-17 Phosphonocephem derivatives, process for the preparation of the same, and use thereof

Publications (2)

Publication Number Publication Date
CY2013003I1 CY2013003I1 (el) 2014-07-02
CY2013003I2 true CY2013003I2 (el) 2015-08-05

Family

ID=18417716

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20091100809T CY1109276T1 (el) 1997-12-19 2009-07-29 Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
CY2013003C CY2013003I2 (el) 1997-12-19 2013-01-07 Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20091100809T CY1109276T1 (el) 1997-12-19 2009-07-29 Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων

Country Status (19)

Country Link
US (1) US6417175B1 (el)
EP (2) EP2080765A1 (el)
JP (3) JP3467418B2 (el)
KR (1) KR100384047B1 (el)
CN (2) CN1194980C (el)
AT (1) ATE430155T1 (el)
AU (1) AU1683299A (el)
BE (1) BE2013C004I2 (el)
CA (1) CA2314564C (el)
CY (2) CY1109276T1 (el)
DE (1) DE69840796D1 (el)
DK (1) DK1043327T3 (el)
ES (1) ES2325139T3 (el)
FR (1) FR13C0008I2 (el)
LU (1) LU92134I2 (el)
NL (1) NL300568I1 (el)
PT (1) PT1043327E (el)
TW (1) TW473479B (el)
WO (1) WO1999032497A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2020416A1 (en) * 2000-08-10 2009-02-04 Takeda Pharmaceutical Company Limited Phosphonocephem compound
US20070238719A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238720A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CN101357929B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有巯基噻二唑的头孢菌素衍生物
KR101599560B1 (ko) * 2007-09-21 2016-03-03 아스트라제네카 아베 비경구 투여에 적합한 세펨 유도체를 함유하는 가용성 제형
CN103212076A (zh) * 2008-08-28 2013-07-24 阿斯利康(瑞典)有限公司 包含头孢洛林的组合物和治疗方法
CA2753387C (en) * 2009-02-23 2017-01-24 Forest Laboratories Holdings Limited Novel cephem compounds useful for the treatment of bacterial infections
MX2012003201A (es) 2009-09-21 2012-05-08 Astrazeneca Ab Composiciones y metodos para tratar infecciones bacterianas utilizando ceftarolina.
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
BR112013032415B1 (pt) 2011-06-17 2021-07-27 Pfizer Anti-Infectives Ab Processos para preparar compostos e compostos
US20140350240A1 (en) 2011-12-07 2014-11-27 Ranbaxy Laboratories Limited Process for preparing ceftaroline salts or hydrates thereof
CA2887391C (en) * 2012-10-19 2019-06-18 Sandoz Ag Novel process for preparing ceftaroline fosamil
CN102977124B (zh) * 2012-12-13 2014-11-26 山东诚创医药技术开发有限公司 7β-[(苯乙酰)氨基]-3-[4-(1-甲基-4-吡啶鎓)-2-噻唑硫基]-3-头孢烯-4-羧酸二苯甲基酯的制备方法
CN104870457B (zh) * 2012-12-20 2017-08-08 桑多斯股份公司 头孢洛林酯的新晶形
CA2939098A1 (en) 2014-02-21 2015-08-27 Micurx Pharmaceuticals, Inc. Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration
CN106565784B (zh) * 2016-10-31 2019-02-26 瑞阳制药有限公司 头孢洛林酯二钠盐的纯化方法
CN110872322B (zh) * 2018-08-29 2022-08-02 上海博志研新药物技术有限公司 乙酸头孢罗膦一水合物及其中间体的制备方法
CN113072567B (zh) * 2021-03-26 2022-10-14 海南海灵化学制药有限公司 一种拉氧头孢钠合成工艺
CN113214323A (zh) * 2021-04-30 2021-08-06 瑞阳制药股份有限公司 分段式头孢罗膦高效稳定析晶方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941999B2 (ja) * 1975-07-24 1984-10-11 武田薬品工業株式会社 セフエムまたはベナム化合物の製造法
JPS5511600A (en) * 1978-07-10 1980-01-26 Fujisawa Pharmaceut Co Ltd Cephem compound, its salt, their preparation and remedy and prophylactic for microbism containing mainly the same
US4268509A (en) * 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
FR2511372A1 (fr) * 1981-08-17 1983-02-18 Rhone Poulenc Sante Nouveaux derives de la cephalosporine et leur preparation
JPS5931791A (ja) * 1982-07-19 1984-02-20 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法、並びに細菌感染症予防・治療剤
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS62238291A (ja) * 1986-04-10 1987-10-19 Fujisawa Pharmaceut Co Ltd セフエム化合物および医薬として許容されるその塩
US4978663A (en) * 1989-08-16 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
JP3514495B2 (ja) 1992-10-02 2004-03-31 エーザイ株式会社 ハロゲン化アミノチアジアゾリル酢酸誘導体の製造法
JP3927262B2 (ja) * 1995-07-19 2007-06-06 武田薬品工業株式会社 セフェム化合物、その製造法および抗菌組成物
JPH10265488A (ja) * 1997-03-27 1998-10-06 Takeda Chem Ind Ltd ホスフォノセフェム誘導体

Also Published As

Publication number Publication date
FR13C0008I2 (fr) 2013-08-16
EP2080765A1 (en) 2009-07-22
AU1683299A (en) 1999-07-12
KR20010015885A (ko) 2001-02-26
CN1194980C (zh) 2005-03-30
NL300568I2 (el) 2016-01-18
ES2325139T3 (es) 2009-08-26
ATE430155T1 (de) 2009-05-15
JP3467418B2 (ja) 2003-11-17
DE69840796D1 (de) 2009-06-10
CY2013003I1 (el) 2014-07-02
CN1679595A (zh) 2005-10-12
LU92134I2 (fr) 2013-03-18
JP2001048893A (ja) 2001-02-20
EP1043327A4 (en) 2001-12-12
KR100384047B1 (ko) 2003-05-14
CA2314564C (en) 2008-11-18
CN1679595B (zh) 2010-05-12
CY1109276T1 (el) 2014-07-02
DK1043327T3 (da) 2009-08-17
FR13C0008I1 (el) 2013-03-22
CA2314564A1 (en) 1999-07-01
US6417175B1 (en) 2002-07-09
TW473479B (en) 2002-01-21
BE2013C004I2 (en) 2018-01-29
PT1043327E (pt) 2009-07-02
JPH11255772A (ja) 1999-09-21
CN1282335A (zh) 2001-01-31
NL300568I1 (el) 2016-01-18
JP2009114202A (ja) 2009-05-28
EP1043327B1 (en) 2009-04-29
EP1043327A1 (en) 2000-10-11
WO1999032497A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
CY2013003I2 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
FI955235A7 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
EE03482B1 (et) Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE03231B1 (et) Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
FI955913A0 (fi) Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
FI951468A7 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
EE04151B1 (et) Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
NO975977L (no) Substituerte purinderivater, fremgangsmÕter for fremstilling og anvendelse derav
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
DE69917327D1 (de) 3,3-biarylpiperidin- und 3,3-biarylmorpholinderivate
EE9800145A (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
FI970997A7 (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
FI954946L (fi) Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö
NO20001288D0 (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
EE03387B1 (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
FI970750L (fi) Indoli-2,3-dioni-3-oksimijohdannaisia, niiden valmistus ja käyttö